These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23689213)

  • 21. A New Era in Pharmacovigilance: Toward Real-World Data and Digital Monitoring.
    Lavertu A; Vora B; Giacomini KM; Altman R; Rensi S
    Clin Pharmacol Ther; 2021 May; 109(5):1197-1202. PubMed ID: 33492663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of data mining in pharmacovigilance.
    Hauben M; Madigan D; Gerrits CM; Walsh L; Van Puijenbroek EP
    Expert Opin Drug Saf; 2005 Sep; 4(5):929-48. PubMed ID: 16111454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring Centre.
    Watson S; Chandler RE; Taavola H; Härmark L; Grundmark B; Zekarias A; Star K; van Hunsel F
    Drug Saf; 2018 Feb; 41(2):203-212. PubMed ID: 28933055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to? A review of the new EU legislation on pharmacovigilance.
    Borg JJ; Aislaitner G; Pirozynski M; Mifsud S
    Drug Saf; 2011 Mar; 34(3):187-97. PubMed ID: 21332243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mining association patterns of drug-interactions using post marketing FDA's spontaneous reporting data.
    Ibrahim H; Saad A; Abdo A; Sharaf Eldin A
    J Biomed Inform; 2016 Apr; 60():294-308. PubMed ID: 26903152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of the MedDRA hierarchy on pharmacovigilance data mining results.
    Pearson RK; Hauben M; Goldsmith DI; Gould AL; Madigan D; O'Hara DJ; Reisinger SJ; Hochberg AM
    Int J Med Inform; 2009 Dec; 78(12):e97-e103. PubMed ID: 19230751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential use of data-mining algorithms for the detection of 'surprise' adverse drug reactions.
    Hauben M; Horn S; Reich L
    Drug Saf; 2007; 30(2):143-55. PubMed ID: 17253879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An Automated System Combining Safety Signal Detection and Prioritization from Healthcare Databases: A Pilot Study.
    Arnaud M; Bégaud B; Thiessard F; Jarrion Q; Bezin J; Pariente A; Salvo F
    Drug Saf; 2018 Apr; 41(4):377-387. PubMed ID: 29185236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Completeness of Spontaneous Adverse Drug Reaction Reports Sent by General Practitioners to a Regional Pharmacovigilance Centre: A Descriptive Study.
    Durrieu G; Jacquot J; Mège M; Bondon-Guitton E; Rousseau V; Montastruc F; Montastruc JL
    Drug Saf; 2016 Dec; 39(12):1189-1195. PubMed ID: 27688025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stevens-Johnson syndrome and toxic epidermal necrolysis: the Food and Drug Administration adverse event reporting system, 2004-2013.
    Abe J; Mataki K; Umetsu R; Ueda N; Kato Y; Nakayama Y; Kinosada Y; Hara H; Inagaki N; Nakamura M
    Allergol Int; 2015 Jul; 64(3):277-9. PubMed ID: 26117261
    [No Abstract]   [Full Text] [Related]  

  • 31. Use of measures of disproportionality in pharmacovigilance: three Dutch examples.
    Egberts AC; Meyboom RH; van Puijenbroek EP
    Drug Saf; 2002; 25(6):453-8. PubMed ID: 12071783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deconstructing the Pharmacovigilance Hype Cycle.
    Hauben M; Reynolds R; Caubel P
    Clin Ther; 2018 Dec; 40(12):1981-1990.e3. PubMed ID: 30545608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of essential information in spontaneous reports of adverse drug reactions in Catalonia-a restraint to the potentiality for signal detection.
    Plessis L; Gómez A; García N; Cereza G; Figueras A
    Eur J Clin Pharmacol; 2017 Jun; 73(6):751-758. PubMed ID: 28251276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of statistical signal detection methods within and across spontaneous reporting databases.
    Candore G; Juhlin K; Manlik K; Thakrar B; Quarcoo N; Seabroke S; Wisniewski A; Slattery J
    Drug Saf; 2015 Jun; 38(6):577-87. PubMed ID: 25899605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Time Series Disturbance Detection for Hypothesis-Free Signal Detection in Longitudinal Observational Databases.
    Whalen E; Hauben M; Bate A
    Drug Saf; 2018 Jun; 41(6):565-577. PubMed ID: 29468602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Statistical and graphical approaches for disproportionality analysis of spontaneously-reported adverse events in pharmacovigilance.
    Zink RC; Huang Q; Zhang LY; Bao WJ
    Chin J Nat Med; 2013 May; 11(3):314-20. PubMed ID: 23725848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The congress of the French Society of Pharmacology and Therapeutics celebrate in Nancy, 20 April 2016, 40 years of French Regional Pharmacovigilance Centres!].
    Jonville-Béra AP; Mallaret M; Sgro C;
    Therapie; 2016 Sep; 71(4):351-4. PubMed ID: 27296805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The future of population-based postmarket drug risk assessment: a regulator's perspective.
    Hammad TA; Neyarapally GA; Iyasu S; Staffa JA; Dal Pan G
    Clin Pharmacol Ther; 2013 Sep; 94(3):349-58. PubMed ID: 23739537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of electronic healthcare record databases in paediatric drug safety surveillance: a retrospective cohort study.
    de Bie S; Coloma PM; Ferrajolo C; Verhamme KM; Trifirò G; Schuemie MJ; Straus SM; Gini R; Herings R; Mazzaglia G; Picelli G; Ghirardi A; Pedersen L; Stricker BH; van der Lei J; Sturkenboom MC;
    Br J Clin Pharmacol; 2015 Aug; 80(2):304-14. PubMed ID: 25683723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postmarketing surveillance of potentially fatal reactions to oncology drugs: potential utility of two signal-detection algorithms.
    Hauben M; Reich L; Chung S
    Eur J Clin Pharmacol; 2004 Dec; 60(10):747-50. PubMed ID: 15619136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.